Here They Go Again: The Democratic Obsession with Drug Price Controls Will Harm Patients and Diminish Innovation
April 26, 2021
The U.S. House of Representatives is once again considering “The Lower Drug Costs Now Act”. It was a bad idea in the last Congress, and it is still bad policy today. If it becomes law, this Act (H.R. 3) empowers the federal government to negotiate prices...